FATE - Fate Therapeutics gets RMAT status from FDA for Lupus treatment April, 14 2025 11:34 AM Fate Therapeutics Inc. 2025-04-14 11:34:06 ET More on Fate Therapeutics Fate Therapeutics Has Promising Off-The-Shelf Cell Therapies While Looking Cheap Seeking Alpha’s Quant Rating on Fate Therapeutics Historical earnings data for Fate Therapeutics Financial information for Fate Therapeutics For further details see: Fate Therapeutics gets RMAT status from FDA for Lupus treatment